Curcumin Nanofiber PCL/PLGA/Collagen Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cells against Liver Fibrosis in Animal Model and Prevented its Recurrence
Open accessAbstract
The aim of this study is preconditioning of hBM-MSCs using curcumin modified nanomembrane to optimize therapy of hepatic fibrosis and preventing its recurrence.Methods: The nanomembrane was prepared by electrospinning technique and characterized using conventional method (cur -nanoscaffold and cur + nanoscaffold).Kinetic release of curcumin was also measured by spectrophotometry.MSCs were isolated from human bone marrow (hBM-MSCs) and cultured on the both nanoscaffolds.We evaluated the in-vivo effect of hBM-MSCs from both nanoscaffold cultures (cur -nanoscaffold/hMSCs and cur + nanoscaffold/MSCs) on liver fibrosis from its effective and preventive points and we assessed the mechanisms of these effects as in vitro studies as cell proliferation, its effect on hepatogenic differentiation, its effect on paracrine release of hBM-MSCs and in-vivo studying the effect on cell migration, survival, engraftment, fate of transplanted cells, modifying the fibrogenic and inflammatory microenvironments. Results:The results of animal model showed that single injection of preconditioning of hBM-MSCs using curcumin modified nanoscaffold ameliorate the fibrosis and prevent its recurrence until 24 weeks of therapy in contrast to improvement but not ameliorative effect of hBM-MSCs/ curcumin negative nanoscaffold which recurred progressively after 12 weeks of therapy.These effects of curcumin modified nanoscaffold were results from its highly efficacy on cell proliferation, in-vitro and in-vivo hepatogenic differentiation, increasing cell migration, engraftment and survival in the inflammatory microenvironment which was markedly improved by down regulation of inflammatory mediators and upregulation of anti-oxidant factors.Conclusion: hBM-MSCs cultured on the prepared curcumin nanomembrane in this study is promising in regenerative therapy for ameliorating the hepatic fibrosis and to prevent its recurrence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Preconditioning MSCs with a curcumin-modified nanomembrane optimized liver fibrosis therapy by enhancing the proliferation, migration, differentiation, and survival of MSCs.
“Tawfeek et al. reported that preconditioning of MSCs using curcumin-modified nanomembrane optimized the therapy of liver fibrosis by enhancing the proliferation, migration, differentiation, and survival of MSCs [359].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [359]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223 · see citing works
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71 · see citing works
Flagged first, then by citations
Research works printed but not linked: 43
- [1]Aithal AP Bairy LK Seetharam RN Kumar N Hepatoprotective effect of bone marrow-derived mesenchymal stromal cells in CCl4-induced liver cirrhosis 3 Biotech 2021 11 2 107. doi:10.1007/s13205-021-02640-y PMC7847925 33564610 · DOI
- [2]Elgharably A Gomaa AI Crossey MM Norsworthy PJ Waked I Taylor-Robinson SD Hepatitis C in Egypt - past, present, and future Int J Gen Med 2016; 20 (10): 1-6 PMC5191841 28053553
- [3]Mazini L Rochette L Amine M Malka G Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs) Int J Mol Sci 2019 20 2523. doi: 10.3390/ijms20102523 31121953 PMC6566837 · DOI
- [4]Oberringer M Bubel M Jennewein M Guthörl S Morsch T Bachmann S The role of adipose-derived stem cells in a self-organizing 3D model with regard to human soft tissue healing Mol Cell Biochem 2018 445 195 210 29305678
- [5]Eom YW Shim KY Baik SK Mesenchymal stem cell therapy for liver fibrosis Korean J Intern Med 2015 30 5 580 589 doi:10.3904/kjim.2015.30.5.580 26354051 PMC4578027 · DOI · Paper page
- [6]Zhao L Hu C Zhang P Jiang H Chen J Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury Stem Cell Res Ther 2018 9 225. https://doi.org/10.1186/s13287-018-0973-3 30139368 PMC6108125 · DOI
- [7]Zhao L Hu C Han F Cai F Wang J Chen J Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation Stem Cell Res Ther 2020 11 1 11 https://doi.org/10.1186/s13287-020-01721-8 32448356 PMC7245776 · DOI
- [8]Srifa W Kosaric N Amorin A Jadi O Park Y Mantri S Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice Nat Commun 2020 11 1 14 https://doi.org/10.1038/ s41467-020-16065-3 32424320 PMC7235221
- [9]Ariyanti AD Zhang J Marcelina O Nugrahaningrum DA Wang G Kasim V Salidroside-pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under hyperglycemia Stem Cells Transl Med 2019 8 404 14 30624028 PMC6431607
- [10]Salehi B Zucca P Sharifi-Rad M Phytotherapeutics in cancer invasion and metastasis Phyther Res 2018 32 1425 1449 29672977
- [11]Huang Y Cao S Zhang Q Zhang H Fan Y Qiu F Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin Arch Biochem Biophys 2018 646 31 7 29596797
- [12]Lee YH Song NY Suh J Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1 Cancer Lett 2018 431 219 229 29807115
- [13]Mirzaei H Shakeri A Rashidi B Jalili A Banikazemi Z Sahebkar A Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies Biomed Pharmacother 2017 85 102 12 27930973
- [14]Mohanty C and Pradhan J, A human epidermal growth factor curcumin bandage bioconjugate loaded with mesenchymal stem cell for in vivo diabetic wound healing, Materials Science & Engineering C (2020), https://doi.org/10.1016/ j.msec.2020.110751 32279771
- [15]Ghavimi MA Bani Shahabadi A Jarolmasjed S Memar MY Maleki Dizaj S Sharifi S Nanofibrous asymmetric collagen/curcumin membrane containing aspirin-loaded PLGA nanoparticles for guided bone regeneration Sci Rep 2020 10 1 18200. doi:10.1038/s41598-020-75454-2 33097790 PMC7584591 · DOI
- [16]Sivani BM Azzeh M Patnaik R Pantea Stoian A Rizzo M Banerjee Y Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions Metabolites 2022 Jul 12 12 7 639 35888763 PMC9320502
- [17]Golchin A Hosseinzadeh S Staji M Soleimani M Ardeshirylajimi A Khojasteh A Biological behavior of the curcumin incorporated chitosan/poly(vinyl alcohol) nanofibers for biomedical applications J Cell Biochem 2019 Sep 120 9 15410 15421 31069851
- [18]Kad A Pundir A Arya SK Bhardwaj N Khatri M An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market J Pharm Innov 2022 17 1 249 265 32983280 PMC7502307
- [19]Sedghi R Shaabani A Mohammadi Z Samadi FY Isaei E Biocompatible electrospinning chitosan nanofibers: a novel delivery system with superior local cancer therapy Carbohydr Polym 2017 159 1 10 28038737
- [20]Maleki Dizaj S Lotfpour F Barzegar-Jalali M Zarrintan M.-H & Adibkia, K Ciprofoxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus. Artif. Cells Nanomed. Biotechnol. 45, 535-543 (2017) 27012878
- [22]Kim DW Choi CH Park JP Lee SJ Nanospheres Loaded with Curcumin Improve the Bioactivity of Umbilical Cord Blood-Mesenchymal Stem Cells via c-Src Activation During the Skin Wound Healing Process Cells 2020 Jun 15 9 6 1467 32549381 PMC7348987
- [23]Qiu B Xu X Yi P Hao Y Curcumin reinforces MSC-derived exosomes in attenuating osteoarthritis via modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 signalling pathways J Cell Mol Med 2020 Sep 24 18 10855 10865 32776418 PMC7521270
- [24]Nazarie Ignat SR Gharbia S Hermenean A Dinescu S Costache M Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies Int J Mol Sci 2021 Dec 10 22 24 13292 34948088 PMC8705326
- [26]Gao Y Yin X Ren X Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control Stem Cells Int 2022 Oct 7 2022 1526217 36248254 PMC9568364
- [27]Yang X Meng Y Han Z Ye F Wei L Zong C Mesenchymal stem cell therapy for liver disease: full of chances and challenges Cell Biosci 2020 27; 10:123 PMC7590738 33117520
- [28]Zhang Z Lin H Shi M Xu R Fu J Lv J Chen L Lv S Li Y Yu S Geng H Jin L Lau GK Wang FS Human umbilical cord mesenchymal stem cells improve liver function and ascites In decompensated liver cirrhosis patients J Gastroenterol Hepatol 2012 Mar 27 Suppl 2 112 20 22320928
- [29]Sakai Y Fukunishi S Takamura M Kawaguchi K Inoue O Usui S Takashima S Seki A Asai A Tsuchimoto Y Nasti A Bich Ho TT Imai Y Yoshimura K Murayama T Yamashita T Arai K Yamashita T Mizukoshi E Honda M Wada T Harada K Higuchi K Kaneko S Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy Regen Ther 2021 21; 18:97-101 PMC8165289 34095367
- [30]Carvalho A.B. Quintanilha L.F. Dias J.V. Paredes B.D. Mannheimer E.G. Carvalho F.G. Asensi K.D. Gutfilen B. Fonseca L.M. Resende C.M. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury Stem Cells 2008 26, 1307-1314 18308943
- [31]Mannheimer E.G. Quintanilha L.F. Carvalho A.B. Paredes B.D. de Carvalho F.G. Takyia C.M. Resende C.M. Rezende G.F.d. de Carvalho A.C.C. Schanaider A. Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model Clin. Transpl 2011 25, 54-60 20047614
- [32]Hu C Wu Z Li L Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases J Cell Mol Med 2020 24 1 40 49 31691463 PMC6933358
- [33]Yousefi F Lavi Arab F Jaafari MR Immunoregulatory, proliferative and anti-oxidant effects of nanocurcuminoids on adipose-derived mesenchymal stem cells EXCLI J 2019 18 405 421 31338010 PMC6635727
- [34]Azam M Ghufran H Butt H Curcumin preconditioning enhances the efficacy of adipose-derived mesenchymal stem cells to accelerate healing of burn wounds Burns Trauma 2021 9 tkab021. doi:10.1093/burnst/tkab021 34514007 PMC8430278 · DOI
- [35]Wiśniewska J Sadowska A Wójtowicz A Słyszewska M Szóstek-Mioduchowska A Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies Life (Basel) 2021 11 10 1068 34685439 PMC8538998
- [36]Tsai PC Fu TW Chen YM Ko TL Chen TH Shih YH Hung SC Fu YS The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis Liver Transpl 2009 May 15 5 484 95 19399744
- [37]Jang YO Kim MY Cho MY Baik SK Cho YZ Kwon SO Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model BMC Gastroenterol 2014 Nov 25 14 198 25425284 PMC4251876
- [38]Laila Mahmoud Montaser1 Gehan Abd-Elfatah Tawfeek1* Dina Shehata Azab2 Sara Ahmed Saied “Therapeutic Efficacy of Bone Marrow Mononuclear Induced Hepatocyte in a Model of Acute Liver Failure by Immunomodulation of IL-17 Pathway” EC Gastroenterology and Digestive System 8.12 (2021): 01-13
- [39]Eom YW Shim KY Baik SK Mesenchymal stem cell therapy for liver fibrosis Korean J Intern Med 2015 30 5 580 9 26354051 PMC4578027
- [40]Gorabi AM Kiaie N Hajighasemi S Jamialahmadi T Majeed M Sahebkar A The Effect of Curcumin on the Differentiation of Mesenchymal Stem Cells into Mesodermal Lineage Molecules 2019 24 22 4029 31703322 PMC6891787
- [41]Khuu DN Nyabi O Maerckx C Sokal E Najimi M Adult human liver mesenchymal stem/progenitor cells participate in mouse liver regeneration after hepatectomy Cell transplantation 2013 22 1369 80 23211283
- [42]Deng J Ouyang P Li W Zhong L Gu C Shen L Cao S Yin L Ren Z Zuo Z Deng J Yan Q Yu S Curcumin Alleviates the Senescence of Canine Bone Marrow Mesenchymal Stem Cells during In vitro Expansion by Activating the Autophagy Pathway Int J Mol Sci 2021 Oct 21 22 21 11356 34768788 PMC8583405
- [43]Bansal MB Chamroonkul N Antifibrotics in liver disease: are we getting closer to clinical use? Hepatol Int 2019 Jan 13 1 25 39 30302735
- [45]Xu X Wang W Lin L Chen P Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats Tissue Cell 2020 66 101382 32933722
- [46]Wang X Gao J Wang Y Zhao B Zhang Y Han F Curcumin pretreatment prevents hydrogen peroxide-induced oxidative stress through enhanced mitochondrial function and deactivation of Akt/Erk signaling pathways in rat bone marrow mesenchymal stem cells Mol Cell Biochem 2018 443 37 45 29052798
Cited by
Sorted by citations
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2 · see citing works
- Authors
- Tawfeek, G. A.-E., Kasem, H. A., & Elshoala, S. E.
- Affiliations
- Menoufia University (EG)
- Corresponding author
- Tawfeek, Gehan Abd-Elfatah
- Venue
- Nanotheranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2023
- Volume
- 7
- Issue
- 3
- Pages
- 299-315
- ISSN
- 2206-7418 (ISSN-L)
- PMC
- PMC10093421
- OpenAlex
- W4364323103
- Cited by
- 8
- References
- 2
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 1
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Nanotheranostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- curcumin, nanofibers, electrospinning, mesenchymal stem cells, bone marrow-derived stem cells, liver fibrosis, hepatocyte differentiation, cell migration, engraftment, inflammatory microenvironment, antioxidant factors, drug release, regenerative therapy
- MeSH terms
- Animals, Collagen, Curcumin, Humans, Liver Cirrhosis, Models, Animal, Nanofibers, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review